Eleven Biotherapeutics reports $6.9 million net loss in second quarter

Eleven Biotherapeutics reported a net loss of $6.9 million, or $0.36 per share, compared with a net loss of $8.1 million, or $0.51 per share, in the same quarter of 2014, according to a press release. Revenue was reported at $0.1 million in the second quarter compared with $0.8 million in the same quarter of 2014.